Amicus Therapeutics, Inc. (FOLD)
NASDAQ: FOLD · Real-Time Price · USD
14.33
-0.01 (-0.07%)
Mar 4, 2026, 4:00 PM EST - Market closed

Amicus Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
634.21528.3399.36329.23305.51
Revenue Growth (YoY)
20.05%32.29%21.30%7.76%17.11%
Cost of Revenue
72.9352.9437.3338.634.47
Gross Profit
561.28475.35362.03290.63271.05
Selling, General & Admin
383.49323.38275.27213.04192.71
Depreciation & Amortization Expenses
7.468.557.875.346.21
Research & Development
135.84109.36152.38276.68272.05
Other Operating Expenses
1.79.193.727.696.51
Total Operating Expenses
528.49450.48439.24502.75477.48
Operating Income
32.7924.88-77.21-212.12-206.43
Interest Income
3.325.417.083.020.51
Interest Expense
-46.16-49.6-50.15-37.12-32.47
Other Non-Operating Income (Expense)
10.24-9.44-29.824.18-3.16
Total Non-Operating Income (Expense)
-32.6-53.63-72.89-29.92-35.12
Pretax Income
0.19-28.76-150.1-242.04-241.55
Provision for Income Taxes
27.327.351.48-5.478.91
Net Income
-27.11-56.11-151.58-236.57-250.46
Net Income to Common
-27.11-56.11-151.58-236.57-250.46
Shares Outstanding (Basic)
308304295289271
Shares Outstanding (Diluted)
308304295289271
Shares Change (YoY)
1.31%3.12%2.11%6.50%4.85%
EPS (Basic)
-0.09-0.18-0.51-0.82-0.92
EPS (Diluted)
-0.09-0.18-0.51-0.82-0.92
Free Cash Flow
29.85-37.44-76.53-170.34-206.38
Free Cash Flow Per Share
0.10-0.12-0.26-0.59-0.76
Gross Margin
88.50%89.98%90.65%88.28%88.72%
Operating Margin
5.17%4.71%-19.33%-64.43%-67.57%
Profit Margin
-4.27%-10.62%-37.96%-71.85%-81.98%
FCF Margin
4.71%-7.09%-19.16%-51.74%-67.55%
EBITDA
40.2533.42-69.34-206.78-200.23
EBITDA Margin
6.35%6.33%-17.36%-62.81%-65.54%
EBIT
32.7924.88-77.21-212.12-206.43
EBIT Margin
5.17%4.71%-19.33%-64.43%-67.57%
Effective Tax Rate
14293.72%-95.11%-0.99%2.26%-3.69%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q